Literature DB >> 18459942

Identification of essential amino acid residues in a sterol 8,7-isomerase from Zea mays reveals functional homology and diversity with the isomerases of animal and fungal origin.

Alain Rahier1, Sylvain Pierre, Geneviève Riveill, Francis Karst.   

Abstract

A putative 8,7SI (sterol 8,7-isomerase) from Zea mays, termed Zm8,7SI, has been isolated from an EST (expressed sequence tag) library and subcloned into the yeast erg2 mutant lacking 8,7SI activity. Zm8,7SI restored endogenous ergosterol synthesis. An in vitro enzymatic assay in the corresponding yeast microsomal extract indicated that the preferred Delta(8)-sterol substrate possesses a single C4alpha methyl group, in contrast with 8,7SIs from animals and fungi, thus reflecting the diversity in the structure of their active site in relation to the distinct sterol biosynthetic pathways. In accordance with the proposed catalytic mechanism, a series of lipophilic ammonium-ion-containing derivatives possessing a variety of structures and biological properties, potently inhibited the Zm8,7SI in vitro. To evaluate the importance of a series of conserved acidic and tryptophan residues which could be involved in the Zm8,7SI catalytic mechanism, 20 mutants of Zm8,7SI were constructed as well as a number of corresponding mutants of the Saccharomyces cerevisiae 8,7SI. The mutated isomerases were assayed in vivo by sterol analysis and quantification of Delta(5,7)-sterols and directly in vitro by examination of the activities of the recombinant Zm8,7SI mutants. These studies have identified His(74), Glu(78), Asp(107), Glu(121), Trp(66) and Trp(193) that are required for Zm8,7SI activity and show that binding of the enzyme-substrate complex is impaired in the mutant T124I. They underline the functional homology between the plant and animal 8,7SIs on one hand, in contrast with the yeast 8,7SI on the other hand, in accordance with their molecular diversity and distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459942     DOI: 10.1042/BJ20080292

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.

Authors:  Claire M Hull; Oliver Bader; Josie E Parker; Michael Weig; Uwe Gross; Andrew G S Warrilow; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

2.  Biosynthetic and iron metabolism is regulated by thiol proteome changes dependent on glutaredoxin-2 and mitochondrial peroxiredoxin-1 in Saccharomyces cerevisiae.

Authors:  Brian McDonagh; C Alicia Padilla; José Rafael Pedrajas; José Antonio Bárcena
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

3.  ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.

Authors:  Suhail Ahmad; Leena Joseph; Josie E Parker; Mohammad Asadzadeh; Steven L Kelly; Jacques F Meis; Ziauddin Khan
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 4.  Biosynthesis of cholesterol and other sterols.

Authors:  W David Nes
Journal:  Chem Rev       Date:  2011-09-08       Impact factor: 60.622

5.  TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease.

Authors:  Luis Sanchez-Pulido; Chris P Ponting
Journal:  Front Genet       Date:  2014-12-11       Impact factor: 4.599

6.  Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition.

Authors:  Tao Long; Abdirahman Hassan; Bonne M Thompson; Jeffrey G McDonald; Jiawei Wang; Xiaochun Li
Journal:  Nat Commun       Date:  2019-06-05       Impact factor: 14.919

7.  Sterol metabolism in the filasterean Capsaspora owczarzaki has features that resemble both fungi and animals.

Authors:  Sebastián R Najle; María Celeste Molina; Iñaki Ruiz-Trillo; Antonio D Uttaro
Journal:  Open Biol       Date:  2016-07       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.